BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22196172)

  • 1. Binding conformation of 2-oxoamide inhibitors to group IVA cytosolic phospholipase A2 determined by molecular docking combined with molecular dynamics.
    Mouchlis VD; Michopoulou V; Constantinou-Kokotou V; Mavromoustakos T; Dennis EA; Kokotos G
    J Chem Inf Model; 2012 Jan; 52(1):243-54. PubMed ID: 22196172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity.
    Antonopoulou G; Magrioti V; Kokotou MG; Nikolaou A; Barbayianni E; Mouchlis VD; Dennis EA; Kokotos G
    Bioorg Med Chem; 2016 Oct; 24(19):4544-4554. PubMed ID: 27522578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location of inhibitors bound to group IVA phospholipase A2 determined by molecular dynamics and deuterium exchange mass spectrometry.
    Burke JE; Babakhani A; Gorfe AA; Kokotos G; Li S; Woods VL; McCammon JA; Dennis EA
    J Am Chem Soc; 2009 Jun; 131(23):8083-91. PubMed ID: 19459633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides.
    Stephens D; Barbayianni E; Constantinou-Kokotou V; Peristeraki A; Six DA; Cooper J; Harkewicz R; Deems RA; Dennis EA; Kokotos G
    J Med Chem; 2006 May; 49(9):2821-8. PubMed ID: 16640343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.
    Vasilakaki S; Barbayianni E; Leonis G; Papadopoulos MG; Mavromoustakos T; Gelb MH; Kokotos G
    Bioorg Med Chem; 2016 Apr; 24(8):1683-95. PubMed ID: 26970660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Oxoamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudodipeptides.
    Barbayianni E; Stephens D; Grkovich A; Magrioti V; Hsu YH; Dolatzas P; Kalogiannidis D; Dennis EA; Kokotos G
    Bioorg Med Chem; 2009 Jul; 17(13):4833-43. PubMed ID: 19443224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.
    Six DA; Barbayianni E; Loukas V; Constantinou-Kokotou V; Hadjipavlou-Litina D; Stephens D; Wong AC; Magrioti V; Moutevelis-Minakakis P; Baker SF; Dennis EA; Kokotos G
    J Med Chem; 2007 Aug; 50(17):4222-35. PubMed ID: 17672443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A(2) enzymes.
    Antonopoulou G; Barbayianni E; Magrioti V; Cotton N; Stephens D; Constantinou-Kokotou V; Dennis EA; Kokotos G
    Bioorg Med Chem; 2008 Dec; 16(24):10257-69. PubMed ID: 18993078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 2-oxoamide inhibitors of human group IVA phospholipase A(2).
    Kokotos G; Kotsovolou S; Six DA; Constantinou-Kokotou V; Beltzner CC; Dennis EA
    J Med Chem; 2002 Jul; 45(14):2891-3. PubMed ID: 12086476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C2-di-ethyl-ceramide-1-phosphate as an inhibitor of group IVA cytosolic phospholipase A2.
    Makiyama T; Nakamura H; Nishida A; Murayama T
    Eur J Pharmacol; 2012 Dec; 697(1-3):144-51. PubMed ID: 23043861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A
    Kokotou MG; Galiatsatou G; Magrioti V; Koutoulogenis G; Barbayianni E; Limnios D; Mouchlis VD; Satpathy B; Navratil A; Dennis EA; Kokotos G
    Sci Rep; 2017 Aug; 7(1):7025. PubMed ID: 28765606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamic characterization of cytosolic phospholipase A2 alpha inhibitors.
    Ramarao MK; Shen MW; Murphy EA; Duan W; Zhao Y; McKew J; Lee KL; Thakker P; Behnke ML; Clark JD
    Anal Biochem; 2008 Dec; 383(2):217-25. PubMed ID: 18801329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
    Forster L; Ludwig J; Kaptur M; Bovens S; Elfringhoff AS; Holtfrerich A; Lehr M
    Bioorg Med Chem; 2010 Jan; 18(2):945-52. PubMed ID: 20005725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A
    Mouchlis VD; Morisseau C; Hammock BD; Li S; McCammon JA; Dennis EA
    Bioorg Med Chem; 2016 Oct; 24(20):4801-4811. PubMed ID: 27320659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of group IVA cytosolic phospholipase A2 by novel 2-oxoamides in vitro, in cells, and in vivo.
    Kokotos G; Six DA; Loukas V; Smith T; Constantinou-Kokotou V; Hadjipavlou-Litina D; Kotsovolou S; Chiou A; Beltzner CC; Dennis EA
    J Med Chem; 2004 Jul; 47(14):3615-28. PubMed ID: 15214789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A
    Smyrniotou A; Kokotou MG; Mouchlis VD; Barbayianni E; Kokotos G; Dennis EA; Constantinou-Kokotou V
    Bioorg Med Chem; 2017 Feb; 25(3):926-940. PubMed ID: 28034646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of secreted phospholipases A₂ by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.
    Mouchlis VD; Magrioti V; Barbayianni E; Cermak N; Oslund RC; Mavromoustakos TM; Gelb MH; Kokotos G
    Bioorg Med Chem; 2011 Jan; 19(2):735-43. PubMed ID: 21216150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phospholipid substrate molecule residing in the membrane surface mediates opening of the lid region in group IVA cytosolic phospholipase A2.
    Burke JE; Hsu YH; Deems RA; Li S; Woods VL; Dennis EA
    J Biol Chem; 2008 Nov; 283(45):31227-36. PubMed ID: 18753135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of catalytic domain residues in interfacial binding and activation of group IV cytosolic phospholipase A2.
    Das S; Cho W
    J Biol Chem; 2002 Jun; 277(26):23838-46. PubMed ID: 11956215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interfacial kinetic and binding properties of mammalian group IVB phospholipase A2 (cPLA2beta) and comparison with the other cPLA2 isoforms.
    Ghomashchi F; Naika GS; Bollinger JG; Aloulou A; Lehr M; Leslie CC; Gelb MH
    J Biol Chem; 2010 Nov; 285(46):36100-11. PubMed ID: 20705608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.